Nonprofit · EIN 84-5185853
PANCREATIC CANCER NORTH AMERICA INC
Tax-exempt · NEW YORK, NY 10022
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $315,717 | $330,991 | -$15,274 | $69,902 | $27,594 | $42,308 |
| December 31, 2024 | 990 | $128,661 | $167,270 | -$38,609 | $69,323 | $11,741 | $57,582 |
| December 31, 2023 | 990 | $140,713 | $150,582 | -$9,869 | $96,001 | $0 | $96,001 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $315,717
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $200,000
- Compensation of officers, directors and key employees
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $54,000
- Accounting fees
- $32,084
- Travel
- $9,454
- Program services (functional)
- $216,153
- Management and general (functional)
- $44,559
- Fundraising (functional)
- $70,279
Balance sheet and other
- Total assets, start of year
- $69,323
- Total assets, end of year
- $69,902
- Total liabilities, end of year
- $27,594
- Net assets, end of year
- $42,308
- Net assets without donor restrictions
- $42,308
- Gross receipts
- $315,717
- Employees
- 0
- Volunteers
- 0
- Year formed
- 2020
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Jonathan Paul | Board Chair Trustee or director | 1 | $0 |
| Michael Gilbert | Board Vice Chair and Treasurer Trustee or director | 1 | $0 |
| Lauren Israel | Board Director Trustee or director | 1 | $0 |
| Russell Browne | Board Director Trustee or director | 1 | $0 |
| Bryan Nese | Board Director Trustee or director | 1 | $0 |
| Michelle Capobianco | President & Secretary Officer | 25 | $0 |
990 for the year ended December 31, 2024: 9 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Jonathan Paul | Board Chair Trustee or director | 1 | $0 |
| Michael Gilbert | Board Vice Chair and Treasurer Trustee or director | 1 | $0 |
| Lauren Israel | Board Director Trustee or director | 1 | $0 |
| Russell Browne | Board Director Trustee or director | 1 | $0 |
| Christopher Andrews | Board Director Trustee or director | 1 | $0 |
| Elfreda Lau | Board Director Trustee or director | 1 | $0 |
| Linda Shick | Board Director Trustee or director | 1 | $0 |
| Richard Weldon | Board Director Trustee or director | 1 | $0 |
| Michelle Capobianco | President & CEO & Secretary Officer | 25 | $0 |
990 for the year ended December 31, 2023: 7 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Ricky Ray Butler | Board Chair Trustee or director | 1 | $0 |
| Anish Kirpalani | Board Director Trustee or director | 1 | $0 |
| Lauren Israel | Board Treasurer Trustee or director | 1 | $0 |
| Jonathan Paul | Board Director Trustee or director | 1 | $0 |
| Richard Weldon | Board Director Trustee or director | 1 | $0 |
| Russell Browne | Board Director Trustee or director | 1 | $0 |
| Michelle Capobianco | President & CEO & Secretary Officer | 25 | $0 |
Address and contacts
- Address (IRS master file)
- 800 3RD AVE FRNT A PMB -1523, NEW YORK, NY 10022-7604
- In care of
- % MICHELLE CAPOBIANCO
- Mailing address (990-N for 2020)
- 4211 Yonge Street - Suite 316, Toronto Ontario M2P 2A9, CA
- Principal officer (990 for 2025)
- Michelle Capobianco, 800 Third Avenue FRNT A - 1523, New York, NY 10022
- Principal officer (990-N for 2020)
- Michelle Capobianco, 4211 Yonge Street - Suite 316, Toronto Ontario M2P 2A9, CA
- Signed the 990
- Michelle Capobianco, President & CEO & Secretary
- Phone
- (844) 274-3640
- Website
- pancone.org
Mission
Pancreatic Cancer North America, Inc. aims to fundamentally change the experience of pancreatic cancer for patients and their families, and redefine it from a death sentence to a survivable cancer. We focus on accelerating research, expanding our programs and supports while increasing awareness and visibility of pancreatic cancer.
Program accomplishments
- Pancreatic Cancer North America, Inc. provided a research grant totaling $200,000 to The University of Texas MD Anderson Cancer Center in support of the 'Multi-omic early detection of pancreatic cancer' research study. This research integrates two powerful tools: blood-based biomarkers and AI-driven imaging analysis of standard CT scans. Together, they create one of the first risk-weighted, dual modality precision screening models for pancreatic cancer--capable of identifying the earliest biological and structural signs of disease, years before symptoms appear. These signals, invisible to the human eye, could unlock the chance to intervene when the disease is still curable.Expenses $200,000 · grants $200,000
- Pancreatic Cancer North America continued its commitment to raising awareness of pancreatic cancer and advocating for greater supports, by working with healthcare professionals, allied organizations and in particular during World Pancreatic Cancer Day.Expenses $16,153
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 84-5185853
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2020
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E60)
- Assets (IRS master file)
- $69,902
- Income (IRS master file)
- $315,717
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $315,717 | $330,991 | $69,902 | IRS |
| 990 | December 2024 | $128,661 | $167,270 | $69,323 | IRS |
| 990 | December 2023 | $140,713 | $150,582 | $96,001 | XML |
| 990 | December 2022 | $223,232 | $255,696 | $116,634 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-N for 2020 Officer: Michelle Capobianco | December 31, 2020 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 84-5185853).
Questions about PANCREATIC CANCER NORTH AMERICA INC
- What is the EIN of PANCREATIC CANCER NORTH AMERICA INC?
- The employer identification number (EIN) of PANCREATIC CANCER NORTH AMERICA INC is 84-5185853.
- Is PANCREATIC CANCER NORTH AMERICA INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
- Are donations to PANCREATIC CANCER NORTH AMERICA INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does PANCREATIC CANCER NORTH AMERICA INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PANCREATIC CANCER NORTH AMERICA INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PANCREATIC CANCER NORTH AMERICA INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of PANCREATIC CANCER NORTH AMERICA INC?
- The 990 for the year ended December 31, 2025 names Michelle Capobianco.
- Who are the officers and directors of PANCREATIC CANCER NORTH AMERICA INC?
- The 990 for the year ended December 31, 2025 lists 6 people; 0 received compensation from the organization.
- How much revenue does PANCREATIC CANCER NORTH AMERICA INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $315,717, expenses of $330,991 and total assets of $69,902 at year end.
Other nonprofits in NEW YORK
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- METROPLUS HEALTH PLAN INC EIN 13-4115686 · last filed 990 for 2024
- HEALTH INSURANCE PLAN OF GREATER NEW YORK EIN 13-1828429 · last filed 990 for 2024
- MOUNT SINAI HOSPITAL EIN 13-1624096 · last filed 990 for 2024
- VNS CHOICE EIN 13-3951057 · last filed 990 for 2024